Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-017001
Filing Date
2013-11-25
Accepted
2013-11-25 15:13:24
Documents
1
Period of Report
2013-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3361
  Complete submission text file 0001179110-13-017001.txt   4703
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SOCIETE GENERALE DE BELGIQUE RUE ROYALE 30 BRUSSELS C9 000000
Business Address
DAVIGNON ETIENNE (Reporting) CIK: 0001198226 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 131240805